Prostate Cancer Clinical Trials in Pittsburgh

Showing 81-100 of 199 trials

Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer

NCT03665922

This study will test whether oral intake of a dietary supplement called BroccoMax®, which is a special blend of broccoli extract containing a chemical called sulforaphane (hereafter abbreviated as SFN), may result in changes in chemicals that feed prostate cancer. BroccoMax® is available over the counter.

Prostate Cancer

University of Pittsburgh39 participantsStarted May 2019

Pittsburgh, Pennsylvania, United States

COMPLETED< 1 mile

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

NCT02380274

The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management. This study will also describe factors influencing treatment decisions including reason(s) for treatment choices and triggers for treatment changes for CRPC as well as describe clinical outcomes based on patient characteristics.

Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer

Astellas Pharma Global Development, Inc.1,030 participantsStarted Mar 2015

Homewood, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +145 more locations

Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Prostate Cancer Trials in Other Cities

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

Hypofractionated SBRT For Prostate Cancer

Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Efficacy and Safety Study of Navarixin (MK-7123) in Combination With Pembrolizumab (MK-3475) in Adults With Selected Advanced/Metastatic Solid Tumors (MK-7123-034)

Stockholm3 Validation Study in a Multi-Ethnic Cohort

Prostate Imaging Using MRI +/- Contrast Enhancement

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer

PK and Dose Escalation and Expansion Study of DST-2970

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Other Conditions in Pittsburgh